Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Field Effects of Dysport vs Botox in Forehead Wrinkles
NCT00989768Phase 4
Key facts
- Status
- Completed
- Start
- May 2005
- Primary completion
- Nov 2007
- Countries
- 1
- Sponsor
- Hexsel Dermatology Clinic
- Modality
- Recombinant Proteins and Enzymes
- Conditions
- forehead wrinkles
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A in forehead wrinkles, sponsored by Hexsel Dermatology Clinic. Primary endpoint: Horizontal Action Halo Diameter at 112 days. Started May 2005; status: completed.
02
Design
1 arm- Study design
- RandomizedDouble-blind
Split-face Dysport vs Botox
Patients receive Dysport on one side of the forehead and Botox on the other.
03
Who it enrols
Adult females with moderate to severe forehead wrinkles and a positive Minor's test for sweating, excluding those with prior recent botulinum toxin treatment or neuromuscular diseases.
04
Endpoints
Primary
Horizontal Action Halo Diameter
Secondary
Compound Muscle Action Potential in m. Frontalis
Beyond the preview
Go deeper on NCT00989768.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989768.